BSX VS MDT Stock Comparison
Performance
BSX100/100
100/100
BSX returned 26.68% in the last 12 months. Based on SPY's performance of -12.97%, its performance is above average giving it a score of 100 of 100.
MDT59/100
59/100
MDT returned -18.84% in the last 12 months. Based on SPY's performance of -20.81%, its performance is above average giving it a score of 59 of 100.
Analyst Price Targets
BSX79/100
79/100
24 analysts offer 12-month price targets for BSX. Together, they have an average target of 57.93, the most optimistic target put BSX at 132 within 12-months and the most pessimistic has BSX at 43.
MDT66/100
66/100
23 analysts offer 12-month price targets for MDT. Together, they have an average target of 109.9, the most optimistic target put MDT at 165 within 12-months and the most pessimistic has MDT at 80.
Technicals
BSX89/100
89/100
BSX receives a 89 of 100 based on 14 indicators. 12 are bullish, 1 are bearish.
MDT14/100
14/100
MDT receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.
Earnings
BSX26/100
26/100
BSX has missed earnings 4 times in the last 20 quarters.
MDT66/100
66/100
MDT has missed earnings 2 times in the last 20 quarters.
Profit
BSX72/100
72/100
Out of the last 20 quarters, BSX has had 18 profitable quarters and has increased their profits year over year on 8 of them.
MDT70/100
70/100
Out of the last 20 quarters, MDT has had 20 profitable quarters and has increased their profits year over year on 7 of them.
Volatility
BSX48/100
48/100
BSX has had a lower than average amount of volatility over the last 12 months giving it a score of 47 of 100.
MDT49/100
49/100
MDT has had a lower than average amount of volatility over the last 12 months giving it a score of 49 of 100.
Dividend
BSX10/100
10/100
BSX's most recent dividend was $0.01 per share, based on a share price of $53.85. It was a payout ratio of -8.24% compared to their total earnings.
MDT100/100
100/100
MDT's most recent dividend was $0.50 per share, based on a share price of $69.43. It was a payout ratio of 60.45% compared to their total earnings.
Sentiment
BSX
"Sentiment" not found for BSX
MDT72/100
72/100
MDT had a bullish sentiment score of 72.19% across Twitter and StockTwits over the last 12 months. It had an average of 246.36 posts, 214,816.46 comments, and 70,151.23 likes per day.
All score calculations are broken down here to help you make more informed investing decisions
Boston Scientific Corp. Summary
New York Stock Exchange / BSX
Healthcare
Medical - Devices
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Medtronic plc Summary
New York Stock Exchange / MDT
Healthcare
Medical - Devices
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare BSX to other companies in the same or a similar industry.